Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease

References

• Toft G, Heide-Jørgensen U, van Haalen H, et al. Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study. J Nephrol. 2020;33(1):1–11.
   PubMed Web of Science ®Google Scholar
• Vestergaard SV, Heide-Jørgensen U, van Haalen H, et al. Risk of anemia in patients with newly identified chronic kidney Disease – A population-based cohort study. Clin Epidemiol. 2020;12:953–962.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Inter. 2012;Suppl 2012:2: 279–335.
   Google Scholar
• Tonelli M, Thadhani R. Anaemia in chronic kidney disease: what do new generation agents offer?. Lancet. 2022;399(10326):702–703.
   PubMed Web of Science ®Google Scholar
• Mima A. Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: advantages and disadvantages. Eur J Pharmacol. 2021;912:174583.
   PubMed Web of Science ®Google Scholar
• Hruska KA, Sugatani T, Agapova O, et al. The chronic kidney disease – Mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80–86.
   PubMed Web of Science ®Google Scholar
• Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422–430.
   PubMed Web of Science ®Google Scholar
• Zheng CM, Wu CC, Lu CL, et al. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients. Int J Med Sci. 2019;16(12):1583–1592.
   PubMed Web of Science ®Google Scholar
• Wan J, Li W, Zhong Y. Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism. J Clin Lab Anal. 2019;33(3):e22696.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang X, Lu Y, et al. Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Sci Rep. 2018;8(1):7743.
   PubMed Web of Science ®Google Scholar
• Chen H, Ren W, Gao Z, et al. Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients. Ren Fail. 2021;43(1):890–899.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Leu JG, Fang YW, et al. High fibroblast growth factor 23 levels associated with low hemoglobin levels in patients with chronic kidney disease stages 3 and 4. Medicine. 2016;95(11):e3049.
   PubMed Web of Science ®Google Scholar
• Mehta R, Cai X, Hodakowski A, et al. Fibroblast growth factor 23 and anemia in the chronic renal insufficiency cohort study. Clin J Am Soc Nephrol. 2017;12(11):1795–1803.
   PubMed Web of Science ®Google Scholar
• Tran L, Batech M, Rhee CM, et al. Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease. Nephrol Dial Transplant. 2016;31(4):636–645.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Lee GH, Miller JE, et al. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis. 2009;53(5):823–834.
   PubMed Web of Science ®Google Scholar
• Tabibzadeh N, Karaboyas A, Robinson BM, et al. The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation. Nephrol Dial Transplant. 2021;36(1):160–169.
   PubMed Web of Science ®Google Scholar
• Thongprayoon C, Neyra JA, Hansrivijit P, et al. Serum klotho in living kidney donors and kidney transplant recipients: a meta-analysis. J Clin Med. 2020;9(6):1834.
   Web of Science ®Google Scholar
• Maique J, Flores B, Shi M, et al. High phosphate induces and klotho attenuates kidney epithelial senescence and fibrosis. Front Pharmacol. 2020;11:1273.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59.
   PubMed Web of Science ®Google Scholar
• Mima A. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. J Diabetes Res. 2013;2013:248563.
   PubMed Web of Science ®Google Scholar
• Mima A, Yasuzawa T, King GL, et al. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio. 2018;8(4):664–670.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing C, Shen C, et al. Diagnostic accuracy study of intraoperative and perioperative serum intact PTH level for successful parathyroidectomy in 501 secondary hyperparathyroidism patients. Sci Rep. 2016;6:26841.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–470.
   PubMed Web of Science ®Google Scholar
• Gluba-Brzózka A, Franczyk B, Olszewski R, et al. The influence of inflammation on anemia in CKD patients. Int J Mol Sci. 2020;21(3):725.
   Web of Science ®Google Scholar
• Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease?. Semin Nephrol. 2009;29(1):3–14.
   PubMed Web of Science ®Google Scholar
• Alemayehu M, Meskele M, Alemayehu B, et al. Prevalence and correlates of anemia among children aged 6–23 months in Wolaita zone, Southern Ethiopia. PLoS One. 2019;14(3):e0206268.
   PubMed Web of Science ®Google Scholar
• Boronat M, Santana Á, Bosch E, et al. Relationship between anemia and serum concentrations of calcium and phosphorus in advanced non-dialysis-dependent chronic kidney disease. Nephron. 2017;135(2):97–104.
   PubMed Web of Science ®Google Scholar
• Misiti J, Spivak JL. Erythropoiesis in vitro. Role of calcium. J Clin Invest. 1979;64(6):1573–1579.
   PubMed Web of Science ®Google Scholar
• Kao CC, Wong HS, Wang YJ, et al. The role of genetic polymorphisms in STIM1 and ORAI1 for erythropoietin resistance in patients with renal failure. Medicine. 2021;100(17):e25243.
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Mucsi I, Czira ME, et al. Association of serum phosphorus level with anemia in kidney transplant recipients. Transplantation. 2011;91(8):875–882.
   PubMed Web of Science ®Google Scholar
• Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10(7):1257–1272.
   PubMed Web of Science ®Google Scholar
• Krajisnik T, Olauson H, Mirza MA, et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int. 2010;78(10):1024–1032.
   PubMed Web of Science ®Google Scholar
• Razzaque MS. Interactions between FGF23 and vitamin D. Endocr Connect. 2022;11(10):e220239.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun Z. Molecular basis of Klotho: from gene to function in aging. Endocr Rev. 2015;36(2):174–193.
   PubMed Web of Science ®Google Scholar
• Milovanov YS, Mukhin NA, Kozlovskaya LV[, et al. Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with stages 3B-4 chronic kidney disease: a new direction of cardionephroprotection] [J]. Ter Arkh. 2016;88(6):21–25.
   PubMed Web of Science ®Google Scholar
• Xu Y, Peng H, Ke B. Alpha-klotho and anemia in patients with chronic kidney disease patients: a new perspective. Exp Ther Med. 2017;14(6):5691–5695.
   PubMed Web of Science ®Google Scholar
• Badve SV, Zhang L, Coombes JS, et al. Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Can J Kidney Health Dis. 2015;2:33.
   PubMedGoogle Scholar
• Rhee CM, Molnar MZ, Lau WL, et al. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014;34(7):732–748.
   PubMed Web of Science ®Google Scholar
• Beige J, Wendt R, Girndt M, et al. Association of serum alkaline phosphatase with mortality in non-selected european patients with CKD5D: an observational, three-Centre survival analysis. BMJ Open. 2014;4(2):e004275.
   PubMed Web of Science ®Google Scholar
• Taliercio JJ, Schold JD, Simon JF, et al. Prognostic importance of serum alkaline phosphatase in CKD stages 3–4 in a clinical population. Am J Kidney Dis. 2013;62(4):703–710.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Komaba H, Fukagawa M. Emerging association between parathyroid hormone and anemia in hemodialysis patients. Ther Apher Dial. 2018;22(3):242–245.
   PubMed Web of Science ®Google Scholar
• Amnuay K, Srisawat N, Wudhikarn K, et al. Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients. Hematol Rep. 2019;11(3):8183.
   PubMed Web of Science ®Google Scholar
• Lewerin C, Ljunggren Ö, Nilsson-Ehle H, et al. Low serum iron is associated with high serum intact FGF23 in elderly men: the swedish MrOS study. Bone. 2017;98:1–8.
   PubMed Web of Science ®Google Scholar
• Agoro R, Montagna A, Goetz R, et al. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. Faseb J. 2018;32(7):3752–3764.
   PubMed Web of Science ®Google Scholar
• Coe LM, Madathil SV, Casu C, et al. FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem. 2014;289(14):9795–9810.
   PubMed Web of Science ®Google Scholar
• Czaya B, Faul C. The role of fibroblast growth factor 23 in inflammation and anemia. Int J Mol Sci. 2019;20(17):4195.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun Z. Regulation of S-formylglutathione hydrolase by the anti-aging gene klotho. Oncotarget. 2017;8(51):88259–88275.
   PubMedGoogle Scholar
• Ghashghaeinia M, Giustarini D, Koralkova P, et al. Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate. Sci Rep. 2016;6:28754.
   PubMed Web of Science ®Google Scholar
• Ellison I, Richie JP.Jr. Mechanisms of glutathione disulfide efflux from erythrocytes. Biochem Pharmacol. 2012;83(1):164–169.
   PubMed Web of Science ®Google Scholar
• Vadakke Madathil S, Coe LM, Casu C, et al. Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis. Am J Pathol. 2014;184(3):827–841.
   PubMed Web of Science ®Google Scholar
• Hu MC, Shi M, Zhang J, et al. Renal production, uptake, and handling of circulating αKlotho. J Am Soc Nephrol. 2016;27(1):79–90.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Yoshida K, Fukuma S, et al. Effects of secondary hyperparathyroidism treatment on improvement in anemia: results from the MBD-5D study. PLoS One. 2016;11(10):e0164865.
   PubMed Web of Science ®Google Scholar
• Zingraff J, Drüeke T, Marie P, et al. Anemia and secondary hyperparathyroidism. Arch Intern Med. 1978;138(11):1650–1652.
   PubMedGoogle Scholar
• Jiang Y, Zhang J, Yuan Y, et al. Association of increased serum leptin with ameliorated anemia and malnutrition in stage 5 chronic kidney disease patients after parathyroidectomy. Sci Rep. 2016;6:27918.
   PubMed Web of Science ®Google Scholar